Clinical Trial Update: Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 dose-ranging trial evaluating the efficacy and safety of acitretin in severe plaque psoriasis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Psoriasis | Phase 4 | Status: COMPLETED